IP Library Granted Patent US 8,673,630
Granted Patent B2
US 8,673,630 · App. 13/128,774 · Granted Mar 18, 2014

βGI-IgG intron for enhanced anti-IGF1R expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,630
App. No.
13/128,774
Granted
Mar 18, 2014
Kind
B2
Abstract

The present invention provides polynucleotides for enhanced expression of a target gene such as an immunoglobulin. Methods of expressing a target gene using the polynucleotides of the invention are also covered.

Claims (7)

1. An isolated plasmid vector comprising the nucleotide sequence set forth in SEQ ID NO: 47.

2. An isolated plasmid vector characterized by a plasmid map set forth in FIG. 9 .

3. An isolated host cell comprising the plasmid vector of claim 1 .

4. The host cell of claim 3 wherein the plasmid vector is integrated into the chromosomal DNA of the host cell.

5. The host cell of claim 4 comprising two or more copies of the plasmid vector.

6. The host cell of claim 3 wherein the plasmid vector is not integrated into the chromosomal DNA of the host cell.

7. The host cell of claim 6 comprising two or more copies of the plasmid vector.

Assignments (3)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2012
From: SAHA, DEBA P.
To: SCHERING CORPORATION
Reel/Frame 027801/0005 →